Viral Inactivation - Global Market Outlook (2017-2023)

Viral Inactivation - Global Market Outlook (2017-2023)

  • Published: October 2017
  • ID: SMRC16791

The Global Viral Inactivation Market is accounted for $1.99 billion in 2016 and expected to grow at a CAGR of 14.9% to reach $5.29 billion by 2023. Factors such as rapid growth in pharmaceutical and biotechnology industries, strong R&D investments in the life sciences industry, high incidence of chronic diseases and increasing number of new drug launches are driving the market growth. However, the high cost of biologics and biosimilars products, development of expensive equipment for viral inactivation are inhibiting the marketspace.

Based on method, the Alkylating agent method segment is considered as the robust & efficient method for inactivation of variety of enveloped viruses.  Alkylating agents are monofunctional or bifunctional. Two mechanisms exist for viral inactivation with alkylating agents. One mechanism involves the modification of proteins, which would cause inhibition of viral cell entry or the release of the genome. Also, Formalin and β-propiolactone (β-PL) are used for inactivation of viruses via chemical reaction along with viral capsid proteins and nucleic acids. Alkylating agents permeate the protein capsid of viruses and chemically inactivate the nucleic acid. The alkylating agent N-acetyl-aziridine is a virus inactivate that has been used in vaccine preparation. 

Based on product, the usage of kits and reagents has increased tremendously. Two nucleic acid extraction buffers available commercially are used to inactivate the viral stocks. These are TRIzol® LS reagent (Invitrogen Corp.) and AVL Buffer from the Qiamp viral RNA mini kit (Qiagen). North America has dominated the market during the forecast period due to adoption of many methods by blood testing centre. According to the FDA, 41 novel drugs were approved. Increase in funding has also resulted in growth in number of FDA approvals over the recent years.

Some of the key players in Global Viral Inactivation market are Macopharma SA, Charles River Laboratories International, Inc., Clean Cells Inc., Danaher Corporation, Merck KGAA, Parker Hannifin Corporation, Rad Source Technologies, Inc., SGS SA, Sartorius AG, Texcell, Inc., Viral Inactivated Plasma Systems SA, Wuxi Pharmatech (Cayman) Inc., Shandong Weigao Group Medical Polymer Company Limited, Cerus Corporation, Terumo BCT, Inc, BioReliance, Thermo Fisher Scientific Inc. and Macopharma SA.

Applications Covered:
• Stem cell products
• Cellular & Gene therapy products
• Blood & Blood tissue products
• Vaccines & Therapeutics
• Tissues & Tissue products

Products Covered:
• Viral inactivation accessories
• Systems and Services
• Kits & Reagents

Methods Covered:
• pH Concentration method
• Alkylating agent method
• Solvent detergent method
• Pasteurization
• Radiation method
• Other Methods

End Users Covered:
• Blood banks and Hospitals
• Academic research institutes
• Pharmaceutical and Biotechnology companies
• Contract Research Organizations
• Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary         
           
2 Preface 
        
 2.1 Abstract         
 2.2 Stake Holders        
 2.3 Research Scope        
 2.4 Research Methodology       
  2.4.1 Data Mining       
  2.4.2 Data Analysis       
  2.4.3 Data Validation       
  2.4.4 Research Approach       
 2.5 Research Sources        
  2.5.1 Primary Research Sources      
  2.5.2 Secondary Research Sources      
  2.5.3 Assumptions       
           
3 Market Trend Analysis        
 3.1 Introduction        
 3.2 Drivers         
 3.3 Restraints        
 3.4 Opportunities        
 3.5 Threats         
 3.6 Application Analysis       
 3.7 Product Analysis        
 3.8 End User Analysis        
 3.9 Emerging Markets        
 3.10 Futuristic Market Scenario       
           
4 Porters Five Force Analysis        
 4.1 Bargaining power of suppliers       
 4.2 Bargaining power of buyers       
 4.3 Threat of substitutes       
 4.4 Threat of new entrants       
 4.5 Competitive rivalry        
           
5 Global Viral Inactivation Market, By Application      
 5.1 Introduction        
 5.2 Stem cell products        
 5.3 Cellular & Gene therapy products      
 5.4 Blood & Blood tissue products       
 5.5 Vaccines & Therapeutics       
 5.6 Tissues & Tissue products       
           
6 Global Viral Inactivation Market, By Product      
 6.1 Introduction        
 6.2 Viral inactivation accessories       
 6.3 Systems and Services       
 6.4 Kits & Reagents        
           
7 Global Viral Inactivation Market, By Method      
 7.1 Introduction        
 7.2 pH Concentration method       
 7.3 Alkylating agent method       
 7.4 Solvent detergent method       
 7.5 Pasteurization        
 7.6 Radiation method        
 7.7 Other Methods        
           
8 Global Viral Inactivation Market, By End User       
 8.1 Introduction        
 8.2 Blood banks and Hospitals       
 8.3 Academic research institutes       
 8.4 Pharmaceutical and Biotechnology companies     
 8.5 Contract Research Organizations      
 8.6 Other End Users        
           
9 Global Viral Inactivation Market, By Geography      
 9.1 Introduction        
 9.2 North America        
  9.2.1 US        
  9.2.2 Canada        
  9.2.3 Mexico        
 9.3 Europe         
  9.3.1 Germany        
  9.3.2 U.K        
  9.3.3 France        
  9.3.4 Italy        
  9.3.5 Spain        
  9.3.6 Rest of Europe       
 9.4 Asia Pacific        
  9.4.1 Japan        
  9.4.2 China        
  9.4.3 India        
  9.4.4 Australia        
  9.4.5 New Zealand       
  9.4.6 South Korea       
  9.4.7 Rest of Asia Pacific       
 9.5 South America        
  9.5.1 Argentina       
  9.5.2 Brazil        
  9.5.3 Chile        
  9.5.4 Rest of South America      
 9.6 Middle East & Africa       
  9.6.1 Saudi Arabia       
  9.6.2 UAE        
  9.6.3 Qatar        
  9.6.4 South Africa       
  9.6.5 Rest of Middle East & Africa      
           
10 Key Developments         
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 10.2 Acquisitions & Mergers       
 10.3 New Product Launch       
 10.4 Expansions        
 10.5 Other Key Strategies       
           
11 Company Profiling         
 11.1 Macopharma SA        
 11.2 Charles River Laboratories International, Inc.     
 11.3 Clean Cells Inc.        
 11.4 Danaher Corporation       
 11.5 Merck KGAA        
 11.6 Parker Hannifin Corporation       
 11.7 Rad Source Technologies, Inc.       
 11.8 SGS SA         
 11.9 Sartorius AG        
 11.10 Texcell, Inc.        
 11.11 Viral Inactivated Plasma Systems SA      
 11.12 Wuxi Pharmatech (Cayman) Inc.      
 11.13 Shandong Weigao Group Medical Polymer Company Limited     
 11.14 Cerus Corporation        
 11.15 Terumo BCT, Inc.        
 11.16 BioReliance        
 11.17 Thermo Fisher Scientific Inc.       
 11.18 Macopharma SA        


List of Tables          
1 Global Viral Inactivation Market Outlook, By Region (2014-2023) ($MN)    
2 Global Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)   
3 Global Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)   
4 Global Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) 
5 Global Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) 
6 Global Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)  
7 Global Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)  
8 Global Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)    
9 Global Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)  
10 Global Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)  
11 Global Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)   
12 Global Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)    
13 Global Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)  
14 Global Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)  
15 Global Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)  
16 Global Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)   
17 Global Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)   
18 Global Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)   
19 Global Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)    
20 Global Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)  
21 Global Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)  
22 Global Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
23 Global Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) 
24 Global Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)   
25 North America Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)   
26 North America Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)  
27 North America Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)  
28 North America Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
29 North America Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) 
30 North America Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) 
31 North America Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) 
32 North America Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)   
33 North America Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) 
34 North America Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)  
35 North America Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)  
36 North America Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)   
37 North America Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) 
38 North America Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) 
39 North America Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) 
40 North America Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)  
41 North America Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)  
42 North America Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)  
43 North America Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)   
44 North America Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) 
45 North America Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) 
46 North America Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
47 North America Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
48 North America Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)  
49 Europe Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)    
50 Europe Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)   
51 Europe Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)   
52 Europe Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) 
53 Europe Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) 
54 Europe Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)  
55 Europe Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)  
56 Europe Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)    
57 Europe Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)  
58 Europe Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)  
59 Europe Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)   
60 Europe Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)    
61 Europe Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)  
62 Europe Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)  
63 Europe Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)  
64 Europe Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)   
65 Europe Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)   
66 Europe Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)   
67 Europe Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)   
68 Europe Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)  
69 Europe Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)  
70 Europe Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
71 Europe Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) 
72 Europe Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)   
73 Asia Pacific Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)   
74 Asia Pacific Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)   
75 Asia Pacific Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)  
76 Asia Pacific Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN) 
77 Asia Pacific Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) 
78 Asia Pacific Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)  
79 Asia Pacific Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) 
80 Asia Pacific Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)   
81 Asia Pacific Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) 
82 Asia Pacific Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)  
83 Asia Pacific Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)  
84 Asia Pacific Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)   
85 Asia Pacific Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) 
86 Asia Pacific Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)  
87 Asia Pacific Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) 
88 Asia Pacific Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)   
89 Asia Pacific Viral Inactivation Market Outlook, By High-energy light (2014-2023) ($MN)  
90 Asia Pacific Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)  
91 Asia Pacific Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)  
92 Asia Pacific Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)   
93 Asia Pacific Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) 
94 Asia Pacific Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) 
95 Asia Pacific Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
96 Asia Pacific Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN) 
97 Asia Pacific Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)  
98 South America Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)   
99 South America Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)  
100 South America Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)  
101 South America Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
102 South America Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN) 
103 South America Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) 
104 South America Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) 
105 South America Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)   
106 South America Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN) 
107 South America Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)  
108 South America Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)  
109 South America Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)   
110 South America Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) 
111 South America Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) 
112 South America Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN) 
113 South America Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)  
114 South America Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)  
115 South America Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)  
116 South America Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)   
117 South America Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) 
118 South America Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN) 
119 South America Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
120 South America Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
121 South America Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)  
122 Middle East & Africa Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)  
123 Middle East & Africa Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)  
124 Middle East & Africa Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN) 
125 Middle East & Africa Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
126 Middle East & Africa Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
127 Middle East & Africa Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN) 
128 Middle East & Africa Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN) 
129 Middle East & Africa Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)  
130 Middle East & Africa Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
131 Middle East & Africa Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN) 
132 Middle East & Africa Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)  
133 Middle East & Africa Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)  
134 Middle East & Africa Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN) 
135 Middle East & Africa Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN) 
136 Middle East & Africa Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
137 Middle East & Africa Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)  
138 Middle East & Africa Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN) 
139 Middle East & Africa Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)  
140 Middle East & Africa Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)  
141 Middle East & Africa Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN) 
142 Middle East & Africa Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
143 Middle East & Africa Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
144 Middle East & Africa Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
145 Middle East & Africa Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN) 

 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials